INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 75 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 3.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $5,000 | -37.5% | 1,250 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $8,000 | -20.0% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $10,000 | +25.0% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $8,000 | -11.1% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $9,000 | -25.0% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $12,000 | 0.0% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $12,000 | +9.1% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $11,000 | +37.5% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $8,000 | +14.3% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $7,000 | -30.0% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $10,000 | 0.0% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $10,000 | -9.1% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $11,000 | -8.3% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $12,000 | -14.3% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $14,000 | – | 1,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Round Table Services, LLC | 129,500 | $1,207,000 | 0.72% |
| STONERIDGE INVESTMENT PARTNERS LLC | 252,376 | $2,352,000 | 0.34% |
| Bellevue Group AG | 155,000 | $1,445,000 | 0.26% |
| WASATCH ADVISORS LP | 1,861,553 | $17,350,000 | 0.26% |
| Blue Clay Capital Management, LLC | 13,000 | $121,000 | 0.14% |
| Virtus ETF Advisers LLC | 24,058 | $224,000 | 0.11% |
| EMERALD ADVISERS, LLC | 203,737 | $1,899,000 | 0.08% |
| Vident Investment Advisory, LLC | 63,383 | $591,000 | 0.08% |
| Thomas J. Herzfeld Advisors, Inc. | 15,000 | $140,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 94,400 | $880,000 | 0.05% |